Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less-Reference-Cited by-同舟云学术

Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less

Published:2016-11-01 Issue:8 Volume:1 Page:945
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Reardon Michael J.¹,Kleiman Neal S.¹,Adams David H.²,Yakubov Steven J.³,Coselli Joseph S.⁴,Deeb G. Michael⁵,O’Hair Daniel⁶,Gleason Thomas G.⁷,Lee Joon Sup⁷,Hermiller James B.⁸,Chetcuti Stan⁵,Heiser John⁹,Merhi William⁹,Zorn George L.¹⁰,Tadros Peter¹⁰,Robinson Newell¹¹,Petrossian George¹¹,Hughes G. Chad¹²,Harrison J. Kevin¹²,Maini Brijeshwar¹³,Mumtaz Mubashir¹³,Conte John V.¹⁴,Resar Jon R.¹⁴,Aharonian Vicken¹⁵,Pfeffer Thomas¹⁵,Oh Jae K.¹⁶,Huang Jian¹⁷,Popma Jeffrey J.¹⁸

Affiliation:

1. Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas

2. Mount Sinai Health System, New York, New York

3. Riverside Methodist Hospital, Columbus, Ohio

4. Texas Heart Institute, CHI St. Luke’s Health, Baylor St. Luke’s Medical Center, Houston

5. University of Michigan Medical Center, Ann Arbor

6. St. Luke's Medical Center/Aurora Health Care, Milwaukee, Wisconsin

7. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

8. St. Vincent Medical Center, Indianapolis, Indiana

9. Spectrum Health Hospitals, Grand Rapids, Michigan

10. The University of Kansas Hospital, Kansas City

11. St. Francis Hospital, Roslyn, New York